Interview
In conversation with
Daniel Fallscheer
Dr. Daniel Fallscheer helped build DasLab, a vendor-neutral lab infrastructure that connected labs, payers, and providers—improving access to diagnostics for more than ten million people. A former Medtronic IHS leader and Siemens Healthineers strategist, he has since shifted to advising and interim roles with a bias for execution over headlines. His stance is consistent: transform care by wiring incentives, partnerships, and patient data rights into the operating model—not by chasing unicorn-style growth.
Inaction isn’t neutral – it’s an implicit decision to let the system keep failing.
Fallscheer’s career through Siemens Healthineers, Medtronic, and DasLab left him skeptical of one-shot “disruption.” What worked at scale was neutral infrastructure that cuts across silos, pragmatic partnerships that move beyond pilots, and a leadership culture that rewards grit and daily delivery. He argues for patient-empowering data rights (purposeful use over fear), clear governance for AI, and work systems built around cross-functional squads and OKRs. For founders and CxOs, the capital playbook is context-dependent: raise early in Europe with operator-angels or family offices, use strategic investors cautiously, bring in global growth capital later—and never let fundraising become the business model. In policy, he advocates agile regulation and harmonized standards so innovators can test safely and scale responsibly. The throughline: build “camels,” not unicorns; align incentives; and treat meaningful partnerships as the engine of adoption.
Lessons from Vendor-Neutral Diagnostics:
Execution Over Hype
What we cover
-
How vendor-neutral lab infrastructure unlocked diagnostic access and cut through silos
-
Why relentless execution, real partnerships, and patient data rights beat one-shot “disruption”
-
What leaders should prioritize—cross-functional squads, OKRs, and governance that enables AI safely
-
Where to look for capital at each stage and why fundraising must not become the business model
-
Which policy shifts—agile regulation, harmonized standards, secure data use—would accelerate adoption across Europe
Daniel Fallscheer is a healthcare leader with 15+ years of experience across startups and corporates. As Co-Founder and CEO of DasLab, he built a vendor-neutral lab infrastructure that improved access to diagnostics for over 10 million people by connecting labs, payers, and providers – cutting through legacy silos. He led strategy, fundraising (10+ million euros), and commercial growth, building a high-performing, remote-first team before transitioning out of the company with his co-founders in late 2024. Prior to DasLab, he launched Florio®, a digital companion for rare disease patients, led Medtronic’s Integrated Health Solutions business in Germany, and drove major strategic programs at Siemens Healthineers, including its IPO preparation and global rebranding.
About
Dr. Daniel Fallscheer
